摘要
目的探讨急性脑梗死采用Solitaire-AB支架取栓术治疗的临床效果。方法分析2019年11月—2020年10月焦作市人民医院75例急性脑梗死患者的临床资料,对入院时基本信息、脑血管病高危因素、血管再通率、术前美国国立卫生院神经功能缺损量表(NIHSS)评分、格拉斯哥昏迷指数(GCS)评分、术后3d和30d NIHSS评分、GCS评分及术后30d改良Rankin评分量表(mRS)评分、术后并发症发生率进行收集分析。对比术前、术后各项指标的差异性。结果 75例患者血管再通率为78.67%(59/75);术后3d和30d NIHSS评分低于术前,差异有统计学意义(P<0.05);术后3d和30d GCS评分高于术前,差异有统计学意义(P<0.05);术后30d mRS评分低于术前,差异有统计学意义(P<0.05);术后并发症发生率为52.00%(39/75)。结论急性脑梗死经Solitaire-AB支架取栓术治疗效果显著,能提高血管再通率、改善神经功能,值得临床运用推广。
Objective To investigate the clinical effect of Solitaire-AB stent thrombectomy in the treatment of acute cerebral infarction. Methods A retrospective analysis from November 2019 to October 2020 in Jiaozuo People’s Hospital clinical data of 75 cases of acute cerebral infarction patients, the basic information on admission, high risk factors of cerebrovascular disease, blood vessels, the rate of preoperative of the us national institutes of health neural function defect scale(NIHSS) score, Glasgow coma scale(GCS) score, postoperative 3 d and 30 d NIHSS score, GCS score and postoperative 30 d modified Rankin rating scale(mRS) score and the postoperative complications incidence were collected and analyzed. The differences of various indicators before and after operation were compared. Results The vascular recanalization rate of 75 patients was 78.67%(59/75). NIHSS scores at 3 d and 30 d after surgery were lower than those before surgery, and the difference was statistically significant(P<0.05). The GCS scores at 3 d and 30 d after surgery were higher than those before surgery, and the difference was statistically significant(P<0.05). The MRS score 30 days after surgery was lower than that before surgery, and the difference was statistically significant(P<0.05). The incidence of postoperative complications was 52.00%(39/75). Conclusion Solitaire-AB stent thrombectomy is effective in the treatment of acute cerebral infarction, which can improve vascular recanalization rate and nerve function, and is worthy of clinical application and promotion.
作者
钱琪
韩凯
冯陆
QIAN Qi;HAN Kai;FENG Lu(Department of Neurology,Jiaozuo Peopled Hospital,Jiaozuo,Henan 454150,China)
出处
《医药论坛杂志》
2022年第1期63-66,共4页
Journal of Medical Forum